An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugs

BACKGROUND: Current therapy of chronic hepatitis C virus (HCV) with direct-acting antivirals (DAAs) has dramatically improved the sustained virologic response (SVR) of affected patients; however, treatment with DAAs remains expensive, and drug-resistant HCV variants remain a threat. As a result, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Permanasari, Adita Ayu, Aoki-Utsubo, Chie, Wahyuni, Tutik Sri, Tumewu, Lidya, Adianti, Myrna, Widyawaruyanti, Aty, Hotta, Hak, Hafid, Achmad Fuad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507375/
https://www.ncbi.nlm.nih.gov/pubmed/34641875
http://dx.doi.org/10.1186/s12906-021-03408-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507375/
https://www.ncbi.nlm.nih.gov/pubmed/34641875
http://dx.doi.org/10.1186/s12906-021-03408-w

Ejemplares similares